These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8946952)

  • 21. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
    Faure P; Oziol L; Artur Y; Chomard P
    Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Frei B
    Biochim Biophys Acta; 1997 Apr; 1345(2):215-21. PubMed ID: 9106501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant/prooxidant effects of dietary non-flavonoid phenols on the Cu2+-induced oxidation of human low-density lipoprotein (LDL).
    Briante R; Febbraio F; Nucci R
    Chem Biodivers; 2004 Nov; 1(11):1716-29. PubMed ID: 17191812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant alpha-keto-carboxylate pyruvate protects low-density lipoprotein and atherogenic macrophages.
    Kang YH; Park SH; Lee YJ; Kang JS; Kang IJ; Shin HK; Park JH; Bünger R
    Free Radic Res; 2002 Aug; 36(8):905-14. PubMed ID: 12420749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL.
    Lynch SM; Frei B
    J Biol Chem; 1995 Mar; 270(10):5158-63. PubMed ID: 7890625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
    Chiu HC; Jeng JR; Shieh SM
    Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis.
    Hogg N; Kalyanaraman B; Joseph J; Struck A; Parthasarathy S
    FEBS Lett; 1993 Nov; 334(2):170-4. PubMed ID: 8224243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of magnoflorine isolated from coptidis rhizoma on Cu2+-induced oxidation of human low density lipoprotein.
    Hung TM; Na M; Min BS; Zhang X; Lee I; Ngoc TM; Thuong PT; Sok DE; Bae K
    Planta Med; 2007 Oct; 73(12):1281-4. PubMed ID: 17973202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans.
    Camejo G; Hurt-Camejo E; Rosengren B; Wiklund O; López F; Bondjers G
    J Lipid Res; 1991 Dec; 32(12):1983-91. PubMed ID: 1816326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycation accelerates the oxidation of low density lipoprotein by copper ions.
    Kobayashi K; Watanabe J; Umeda F; Nawata H
    Endocr J; 1995 Aug; 42(4):461-5. PubMed ID: 8556051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
    Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of medium components on Cu(2+)-dependent oxidation of low-density lipoproteins and its sensitivity to superoxide dismutase.
    Thomas CE
    Biochim Biophys Acta; 1992 Sep; 1128(1):50-7. PubMed ID: 1390878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting resistance of low density lipoproteins to oxidation.
    Ziouzenkova O; Gieseg SP; Ramos P; Esterbauer H
    Lipids; 1996 Mar; 31 Suppl():S71-6. PubMed ID: 8729097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Huajiao volatile oil on Cu2+ -induced oxidative modification of low density lipoprotein in vitro].
    Ma JY; Shi YK; Fang DZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):63-5. PubMed ID: 16468644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of heparin on Cu(2+)-mediated oxidation of human low-density lipoproteins.
    Albertini R; Rindi S; Passi A; Palladini G; Pallavicini G; De Luca G
    FEBS Lett; 1995 Dec; 377(2):240-2. PubMed ID: 8543059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein.
    Malo-Ranta U; Ylä-Herttuala S; Metsä-Ketelä T; Jaakkola O; Moilanen E; Vuorinen P; Nikkari T
    FEBS Lett; 1994 Jan; 337(2):179-83. PubMed ID: 8287973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.
    Iuliano L; Colavita AR; Camastra C; Bello V; Quintarelli C; Alessandroni M; Piovella F; Violi F
    Br J Pharmacol; 1996 Dec; 119(7):1438-46. PubMed ID: 8968553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis.
    Chang YC; Huang KX; Huang AC; Ho YC; Wang CJ
    Food Chem Toxicol; 2006 Jul; 44(7):1015-23. PubMed ID: 16473450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antioxidant and anti-inflammatory activities of Jaceosidin from Artemisia princeps Pampanini cv. Sajabal.
    Kim MJ; Han JM; Jin YY; Baek NI; Bang MH; Chung HG; Choi MS; Lee KT; Sok DE; Jeong TS
    Arch Pharm Res; 2008 Apr; 31(4):429-37. PubMed ID: 18449499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M; Módy E
    Rom J Intern Med; 1997; 35(1-4):55-62. PubMed ID: 9562653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.